99% Savings - Buy Just @1 Rs X
Gluformin I 1g Tablet PR is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Diabetes.
The optimal dosage of Gluformin I 1g Tablet PR is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Gluformin I 1g Tablet PR include Stomach Upset, Difficulty urinating. Apart from the aforementioned side effects, Gluformin I 1g Tablet PR can also lead to other problems, which have been listed below. Usually, these side effects of Gluformin I 1g Tablet PR go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Gluformin I 1g Tablet PR's effect is Mild during pregnancy and Moderate for lactating mothers. It is important to know if Gluformin I 1g Tablet PR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gluformin I 1g Tablet PR related warnings section.
Gluformin I 1g Tablet PR is contraindicated in people with pre-existing medical conditions like Congestive Heart Failure (CHF), Anemia, Shock as it can result in adverse effects. Some other conditions that can be affected by Gluformin I 1g Tablet PR are listed in the contraindications section below.
Drug reaction of Gluformin I 1g Tablet PR with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Gluformin I 1g Tablet PR is safe while driving, and is is addictive in nature.
Gluformin I 1g Tablet PR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Gluformin I 1g Tablet PR safe for pregnant women?
Pregnant women may get mild side effects from Gluformin I.
Is the use of Gluformin I 1g Tablet PR safe during breastfeeding?
Gluformin I can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Gluformin I 1g Tablet PR on the Kidneys?
Gluformin I does not damage the kidneys.
What is the effect of Gluformin I 1g Tablet PR on the Liver?
Gluformin I does not damage the liver.
What is the effect of Gluformin I 1g Tablet PR on the Heart?
Gluformin I is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Gluformin I 1g Tablet PR unless your doctor advises you to do so -
Is this Gluformin I 1g Tablet PR habit forming or addictive?
Gluformin I 1g Tablet PR does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Gluformin I 1g Tablet PR since it does not cause drowsiness.
Is it safe?
Yes, but consume Gluformin I 1g Tablet PR only on doctor's advice.
Is it able to treat mental disorders?
No, Gluformin I 1g Tablet PR cannot treat any kind of mental disorder.
Interaction between Food and Gluformin I 1g Tablet PR
Information is not available on the interaction of any foods with Gluformin I 1g Tablet PR, due to a lack of research on this.
Interaction between Alcohol and Gluformin I 1g Tablet PR
Consuming Gluformin I 1g Tablet PR with alcohol can have many serious effects on your body.
Gluformin I increases the sensitivity of insulin, young women with PCOS often have elevated insulin levels and are more likely to develop diabetes. It is often prescribed for women with PCOS to help prevent diabetes. A lifestyle that includes healthy nutrition and daily exercise is the most important part of a PCOS treatment plan.
Yes, Gluformin I is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
Yes, you can take Gluformin I with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Gluformin I and long-term use can increase lactic acid and uric acid in the blood.
Gluformin I should be taken with food to reduce stomach and bowel side effects, which may experience the first few weeks of treatment. Also, exercise regularly and test for sugar in your blood or urine as directed.
Yes, Gluformin I can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826